These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 34197574)
1. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574 [TBL] [Abstract][Full Text] [Related]
2. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C; Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361 [TBL] [Abstract][Full Text] [Related]
3. Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B. Dezanet LNC; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A Liver Int; 2021 Dec; 41(12):2874-2884. PubMed ID: 34297463 [TBL] [Abstract][Full Text] [Related]
4. Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana. Stockdale AJ; Phillips RO; Beloukas A; Appiah LT; Chadwick D; Bhagani S; Bonnett L; Sarfo FS; Dusheiko G; Geretti AM; Clin Infect Dis; 2015 Sep; 61(6):883-91. PubMed ID: 26021992 [TBL] [Abstract][Full Text] [Related]
5. Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications. Boyd A; Gozlan J; Maylin S; Delaugerre C; Peytavin G; Girard PM; Zoulim F; Lacombe K Hepatology; 2014 Aug; 60(2):497-507. PubMed ID: 24752996 [TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study. Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068 [TBL] [Abstract][Full Text] [Related]
7. Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity. Audsley J; Bent SJ; Littlejohn M; Avihingsanon A; Matthews G; Bowden S; Bayliss J; Luciani F; Yuen L; Fairley CK; Locarnini S; Lewin SR; Sasadeusz J AIDS; 2016 Jun; 30(10):1597-606. PubMed ID: 26950313 [TBL] [Abstract][Full Text] [Related]
8. Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression. Huang AJ; Núñez M J Int Assoc Provid AIDS Care; 2015; 14(4):360-8. PubMed ID: 25999329 [TBL] [Abstract][Full Text] [Related]
9. Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study. Dezanet LNC; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A J Antimicrob Chemother; 2021 Oct; 76(11):3009-3019. PubMed ID: 34458919 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy. Weissmann L; Picone CM; Gouvêa MSG; Ferreira PRA; Viana MSVB; Pinho JRR; Cassenote AJF; Segurado AC Braz J Infect Dis; 2019; 23(6):441-450. PubMed ID: 31715124 [TBL] [Abstract][Full Text] [Related]
11. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus. Boyd A; Gozlan J; Miailhes P; Lascoux-Combe C; Cam MS; Rougier H; Zoulim F; Girard PM; Lacombe K AIDS; 2015 Sep; 29(15):1963-73. PubMed ID: 26153669 [TBL] [Abstract][Full Text] [Related]
12. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia. Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G; Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504 [TBL] [Abstract][Full Text] [Related]
13. Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus. Matthews GV; Seaberg EC; Avihingsanon A; Bowden S; Dore GJ; Lewin SR; Sasadeusz J; Revill PA; Littlejohn M; Hoy JF; Finlayson R; Ruxrungtham K; Saulynas M; Locarnini S; Thio CL Clin Infect Dis; 2013 May; 56(9):e87-94. PubMed ID: 23315316 [TBL] [Abstract][Full Text] [Related]
14. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. Huang YS; Chang SY; Sheng WH; Sun HY; Lee KY; Chuang YC; Su YC; Liu WC; Hung CC; Chang SC PLoS One; 2016; 11(12):e0169228. PubMed ID: 28033344 [TBL] [Abstract][Full Text] [Related]
15. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia. Vinikoor MJ; Hamusonde K; Muula G; Asombang M; Riebensahm C; Chitundu H; Sunkuntu-Sichizya V; Bhattacharya D; Sinkala E; Lauer G; Chung R; Mbewe W; Egger M; Bosomprah S; Wandeler G Clin Infect Dis; 2024 Jun; 78(6):1583-1590. PubMed ID: 37997691 [TBL] [Abstract][Full Text] [Related]
16. Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure? Audsley J; Avihingsanon A; Littlejohn M; Bowden S; Matthews GV; Fairley CK; Lewin SR; Sasadeusz J J Acquir Immune Defic Syndr; 2020 Aug; 84(5):527-533. PubMed ID: 32692112 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia. Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044 [TBL] [Abstract][Full Text] [Related]
19. Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection. Huang YS; Sun HY; Chang SY; Chuang YC; Cheng A; Huang SH; Huang YC; Chen GJ; Lin KY; Su YC; Liu WC; Hung CC Hepatol Int; 2019 Jul; 13(4):431-439. PubMed ID: 31177505 [TBL] [Abstract][Full Text] [Related]
20. Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy. Lewin SR; Ribeiro RM; Avihingsanon A; Bowden S; Matthews G; Marks P; Locarnini SA; Ruxrungtham K; Perelson AS; Dore GJ Hepatology; 2009 Apr; 49(4):1113-21. PubMed ID: 19115219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]